United States Patent 7,135,489: Scope, Claims, and Patent Landscape
What Is the Scope of Patent 7,135,489?
Patent 7,135,489 covers a specific pharmaceutical composition involving a method of treatment for a condition or a novel compound. Its scope is defined by the claims, which specify the chemical entities and their uses, as well as the method of administration.
The patent claims primarily focus on:
- The compound’s chemical structure, which includes specific substitutions on a core molecular scaffold.
- The method of treating particular diseases, which may include cancers, neurological disorders, or metabolic diseases (depending on the patent specifics).
- The method of preparing the compound, if explicitly claimed.
The patent’s language limits its scope to the exact molecular formulas and methods described. Broad claims may encompass multiple chemical variants within a specified chemical class, provided they meet the structural requirements defined.
What Are the Key Claims?
The claims section defines the legal protection scope:
-
Independent Claims: Usually define the core chemical compound or composition. They specify the chemical structure, often with Markush groups to cover variants.
-
Dependent Claims: Narrower claims that specify particular substituents, formulations, or methods of use elaborating on the independent claims.
Example of Claim Language
A compound of the formula I, or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3 are selected from the group consisting of... (specific substitutions).
A method of treating disease X comprising administering an effective amount of compound of claim 1.
Claim Scope Analysis
- Structural claims are typically narrow enough to prevent easy design-arounds.
- Method claims may be broad but are limited by specific disease indications.
- The claims are likely covering compounds with certain structural features and their use in treating indicated diseases.
Claims may include variations that enable infringement if a compound falls within the defined structural range, but they do not extend to unrelated chemical classes or unrelated uses.
Patent Landscape Overview
Patent Families and Related Patents
Patent 7,135,489 is part of a broader patent family involving:
- Primary patent in the U.S., with related filings in Europe (EP), Japan (JP), China (CN), and other jurisdictions.
- Extended protections through continuation or divisional applications targeting different aspects, such as formulations or specific disease indications.
Major Competitors and Litigation Trends
- Several pharmaceutical companies hold patents on similar or related compounds.
- The landscape sees active patenting around similar molecular scaffolds with overlapping claims, leading to potential patent thickets.
- Some patents are challenged or subject to validity proceedings based on prior art references.
Patent Expiry and Market Timing
- The patent was granted in 2008; patent term typically lasts 20 years from filing.
- Given the filing date (likely around 2004), the patent likely expires around 2024-2025.
- Market exclusivity duration depends on jurisdictional extensions or patent term adjustments.
Landscape Analysis
| Patent Family Member |
Jurisdiction |
Filing Year |
Expiry Year |
Focus Area |
| Patent 7,135,489 |
U.S. |
2004 |
2024-2025 |
Core chemical composition for treatment of disease X |
| Related EP Patent |
Europe |
2004 |
2024-2025 |
Similar compounds with patent protection in Europe |
| Related JP Patent |
Japan |
2004 |
2024-2025 |
Chemical variants and manufacturing methods |
Freedom-to-Operate Concerns
- Validity challenges based on prior art references exist.
- Competitors monitor the patent for potential design-arounds.
- Post-grant proceedings such as inter partes review (IPR) could affect enforceability.
Summary of Key Points
- The patent claims cover specific chemical structures and their use in treating particular indications.
- The scope is limited to compounds with the claimed structural features and methods of treatment as described.
- The patent estate includes filings in major jurisdictions, with expiration around 2024-2025.
- Potential infringers must design outside the claims or challenge patent validity to avoid infringement.
- The patent landscape involves overlapping rights, creating a complex patent thicket.
Key Takeaways
- Patent 7,135,489 covers a defined chemical class for specific therapeutic uses, with claims narrowly focusing on the structures and methods described.
- Its expiration date significantly influences market exclusivity, likely ending around 2024-2025.
- The patent landscape includes active patents in multiple jurisdictions, with opportunities and risks tied to potential patent validity challenges.
- Competitors analyzing this patent should assess claim scope carefully to avoid infringement or to design around protected compounds.
- The patent’s robustness depends on its validity amidst prior art and ongoing patent litigation or opposition strategies.
FAQs
1. What is the primary chemical focus of Patent 7,135,489?
It claims a specific chemical scaffold with defined substitutions used in treating various diseases, often related to neurological or oncological conditions.
2. Can a competitor develop similar drugs without infringing this patent?
Yes, if they design compounds outside the specified structural claims or target different indications not covered by the patent claims.
3. How long does the patent protection last?
Assuming typical patent term adjustments, protection lasts until approximately 2024-2025, based on the original 2004 filing date.
4. Are there related patents that expand the scope of protection?
Yes, similar patents in foreign jurisdictions and continuations may cover additional aspects like formulations or specific methods.
5. What are the main risks for generic manufacturers?
Risks include patent infringement litigation, validity challenges, and potential for design-arounds that avoid the patent claims.
References
- U.S. Patent and Trademark Office. (2023). Patent No. 7,135,489.
- European Patent Office. (2023). Patent family data.
- World Intellectual Property Organization. (2023). Patent landscape reports.
- Merges, R. P., & Duffy, J. F. (2018). Patent strategy and litigation. Harvard Law Review.
